Endoscopy devices for obesity, type II diabetes and NASH market was valued at $2,638.99 million in 2019, and is projected to reach $3,711.43 million by 2028.

PORTLAND, OREGON, UNITED STATES, August 30, 2022 /EINPresswire.com/ -- The global endoscopy devices for obesity, type II diabetes and NASH market is driven by surge in obese population across the globe. Furthermore, the market is also supplemented by growth in diabetic and NASH population. In addition, upsurge in popularity of weight loss treatments using endoscopy among patient population is also anticipated to boost the market growth throughout the forecast period.

The global endoscopy devices for obesity, type II diabetes and NASH market was valued at $2,638.99 million in 2019, and is projected to reach $3,711.43 million by 2028, registering a CAGR of 7.6% from 2021 to 2028.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/12076

Rise in obese population, surge in prevalence of chronic diseases that require endoscopy devices, shorter recovery time and minimal postoperative complications, and favorable FDA approvals have boosted the growth of the global endoscopy devices for obesity, type II diabetes and NASH market. Moreover, advancements in technologies and rise in patient preference for minimally invasive surgeries supplement the market growth. However, infections caused by endoscopes and lack of skilled physicians and endoscopists hamper the market growth. On the contrary, unmet medical needs in the developing countries would open lucrative opportunities for the market players in the future.

Covid-19 scenario:

The pandemic affected the import & export of raw materials due to lockdown in several countries. Moreover, increase in prevalence of Covid-19 among healthcare workers led to short supply of endoscopy devices.
Several governments imposed strict regulations regarding social distancing, which resulted in closure of manufacturing facilities. This increased the gap between supply and demand.
The delayed shipments and production schedules coupled with delay in surgical procedures for safety reasons negatively affected the market.
The global endoscopy devices for obesity, type II diabetes and NASH market is categorized on the basis of product, procedure, disease indication, and region.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/12076

Based on product, the market is segmented into endoscope, mechanical endoscopic equipment, visualization and documentation systems, accessories, and other endoscopy equipment. The endoscope segment held the lion’s share in 2019, contributing to around three-fifths of the market. Moreover, the segment is expected to showcase the highest CAGR of 8.2% during the forecast period.

On the basis of procedure, the market is classified into gastric balloon, aspiration therapy, endoscopic sleeve gastroplasty, gastric injection, and lap band surgery. The endoscopic sleeve gastroplasty segment dominated the market in 2019, accounting for more than three-fifths of the market. The segment is expected to manifest the highest CAGR of 8.2% during the forecast period.

The global endoscopy devices for obesity, type II diabetes and NASH market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across Europe held the largest share in 2019, contributing to nearly two-fifths of the market. However, the market across Asia-Pacific is projected to register the highest CAGR of 9.6% during the forecast period.

The global endoscopy devices for obesity, type II diabetes and NASH market report includes an in-depth analysis of the prime market players such as Fractyl Laboratories, Apollo Endosurgery, GI Windows, GI Dynamics, Reshape LifeSciences, Inc., Aspire Bariatrics, Obalon Therapeutics, USGI Medical, Spatz Fgia and Endo Tools Therapeutics.

We also Offers Regional and Country Reports-

Japan Endoscopy Devices for Obesity, Type II Diabetes and NASH Market
South Korea Endoscopy Devices for Obesity, Type II Diabetes and NASH Market
Singapore Endoscopy Devices for Obesity, Type II Diabetes and NASH Market
China Endoscopy Devices for Obesity, Type II Diabetes and NASH Market
Indonesia Endoscopy Devices for Obesity, Type II Diabetes and NASH Market
Australia Endoscopy Devices for Obesity, Type II Diabetes and NASH Market
Taiwan Endoscopy Devices for Obesity, Type II Diabetes and NASH Market

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.